Prague Med. Rep. 2023, 124, 242-254

https://doi.org/10.14712/23362936.2023.19

The Predictive Value of Serum Aldosterone Level for Coronary Artery Calcium Score in Patients with Chronic Kidney Disease: A Single-center Study

Viktor V. Semenov1, Jizzo R. Bosdriesz2, Olexandr Kuryata1

1Department of Internal Medicine 2 and Phthisiology, Dnipro State Medical University, Dnipro, Ukraine
2ERA-EDTA Registry, Department of Medical Informatics, Amsterdam UMC, University of Amsterdam, Amsterdam Public Health Research Institute, Amsterdam, The Netherlands

Received September 21, 2022
Accepted August 27, 2023

References

1. Arnett, D. K., Blumenthal, R. S., Albert, M. A., Buroker, A. B., Goldberger, Z. D., Hahn, E. J., Himmelfarb, C. D., Khera, A., Lloyd-Jones, D., McEvoy, J. W., Michos, E. D., Miedema, M. D., Muñoz, D., Smith, S. C., Virani, S. S., Williams, K. A., Yeboah, J., Ziaeian, B. (2019) 2019 ACC/AHA Guideline on the primary prevention of cardiovascular disease: Executive summary: A report of the American College of Cardiology/American Heart Association Task Force on clinical practice guidelines. Circulation 140(11), e563–e595.
2. Chen, J., Budoff, M. J., Reilly, M. P., Yang, W., Rosas, S. E., Rahman, M., Zhang, X., Roy, J. A., Lustigova, E., Nessel, L., Ford, V., Raj, D., Porter, A. C., Soliman, E. Z., Wright, J. T. Jr., Wolf, M., He, J.; CRIC Investigators (2017) Coronary artery calcification and risk of cardiovascular disease and death among patients with chronic kidney disease. JAMA Cardiol. 2(6), 635–643. <https://doi.org/10.1001/jamacardio.2017.0363>
3. Chen, S.-C., Huang, J.-C., Su, H.-M., Chiu, Y.-W., Chang, J.-M., Hwang, S.-J., Chen, H.-C. (2018) Prognostic cardiovascular markers in chronic kidney disease. Kidney Blood Press. Res. 43(4), 1388–1407. <https://doi.org/10.1159/000492953>
4. D’Agostino, R. B., Vasan, R. S., Pencina, M. J., Wolf, P. A., Cobain, M., Massaro, J. M., Kannel, W. B. (2008) General cardiovascular risk profile for use in primary care: The Framingham heart study. Circulation 117(6), 743–753. <https://doi.org/10.1161/CIRCULATIONAHA.107.699579>
5. De Lemos, J. A., Ayers, C. R., Levine, B., DeFilippi, C. R., Wang, T. J., Hundley, W. G., Berry, J. D., Seliger, S. L., McGuire, D. K., Ouyang, P., Drazner, M. H., Budoff, M., Greenland, P., Ballantyne, C. M., Khera, A. (2017) Multimodality strategy for cardiovascular risk assessment: Performance in 2 population-based cohorts. Circulation 135(22), 2119–2132. <https://doi.org/10.1161/CIRCULATIONAHA.117.027272>
6. DeLong, E. R., DeLong, D. M., Clarke-Pearson, D. L. (1988) Comparing the areas under two or more correlated receiver operating characteristic curves: A nonparametric approach. Biometrics 44(3), 837–845. <https://doi.org/10.2307/2531595>
7. Donderski, R., Stróżecki, P., Sulikowska, B., Grajewska, M., Miśkowiec, I., Stefańska, A., Siódmiak, J., Odrowąż-Sypniewska, G., Manitius, J. (2017) Aldosterone antagonist therapy and its relationship with inflammation, fibrosis, thrombosis, mineral-bone disorder and cardiovascular complications in peritoneal dialysis (PD) patients. Int. Urol. Nephrol. 49(10), 1867–1873. <https://doi.org/10.1007/s11255-017-1655-2>
8. Eknoyan, G., Lameire, N., Echardt, K., Kasiske, B., Wheeler, D. (2013) KDIGO 2012 Clinical Practice Guideline for the evaluation and management of chronic kidney disease. Kidney Int. Suppl. 3(1), 1–150.
9. Firke, S. (2020) janitor: Simple Tools for Examining and Cleaning Dirty Data (R package version 1.2.1). Available at: https://CRAN.R-project.org/package=janitor
10. Funder, J. W. (2017) Spironolactone in cardiovascular disease: An expanding universe? F1000Res. 6, 1738. <https://doi.org/10.12688/f1000research.11887.1>
11. Güder, G., Bauersachs, J., Frantz, S., Weismann, D., Allolio, B., Ertl, G., Angermann, C. E., Störk, S. (2007) Complementary and incremental mortality risk prediction by cortisol and aldosterone in chronic heart failure. Circulation 115(13), 1754–1761. <https://doi.org/10.1161/CIRCULATIONAHA.106.653964>
12. Hayashi, K., Suzuki, T., Sakamaki, Y., Ito, S. (2018) Cardiac hypertrophy in chronic kidney disease – Role of aldosterone and FGF23. Ren. Replace. Ther. 4(1), 10. <https://doi.org/10.1186/s41100-018-0152-0>
13. Judd, E., Calhoun, D. A. (2015) Management of hypertension in CKD: Beyond the guidelines. Adv. Chronic Kidney Dis. 22(2), 116–122. <https://doi.org/10.1053/j.ackd.2014.12.001>
14. Knuuti, J., Wijns, W., Saraste, A., Capodanno, D., Barbato, E., Funck-Brentano, C., Prescott, E., Storey, R. F., Deaton, C., Cuisset, T., Agewall, S., Dickstein, K., Edvardsen, T., Escaned, J., Gersh, B. J., Svitil, P., Gilard, M., Hasdai, D., Hatala, R., Mahfoud, F., Masip, J., Muneretto, C., Valgimigli, M., Achenbach, S., Bax, J. J.; ESC Scientific Document Group (2020) 2019 ESC Guidelines for the diagnosis and management of chronic coronary syndromes. Eur. Heart J. 41(3), 407–477. <https://doi.org/10.1093/eurheartj/ehz425>
15. Kobayashi, M., Stienen, S., Maaten, J. M., Dickstein, K., Samani, N. J., Lang, C. C., Ng, L. L., Anker, S. D., Metra, M., Preud’homme, G., Duarte, K., Lamiral, Z., Girerd, N., Rossignol, P., Veldhuisen, D. J., Voors, A. A., Zannad, F., Ferreira, J. P. (2020) Clinical determinants and prognostic implications of renin and aldosterone in patients with symptomatic heart failure. ESC Heart Fail. 7(3), 953–963. <https://doi.org/10.1002/ehf2.12634>
16. Kramer, A., Pippias, M., Noordzij, M., Stel, V. S., Andrusev, A. M., Aparicio-Madre, M. I., Arribas Monzón, F. E., Åsberg, A., Barbullushi, M., Beltrán, P., Bonthuis, M., Caskey, F. J., Castro de la Nuez, P., Cernevskis, H., De Meester, J., Finne, P., Golan, E., Heaf, J. G., Hemmelder, M. H., Ioannou, K., Kantaria, N., Komissarov, K., Korejwo, G., Kramar, R., Lassalle, M., Lopot, F., Macário, F., Mackinnon, B., Pálsson, R., Pechter, Ü., Piñera, V. C., Santiuste de Pablos, C., Segarra-Medrano, A., Seyahi, N., Slon Roblero, M. F., Stojceva-Taneva, O., Vazelov, E., Winzeler, R., Ziginskiene, E., Massy, Z., Jager, K. J. (2019) The European Renal Association – European Dialysis and Transplant Association (ERA-EDTA) Registry Annual Report 2016: A summary. Clin. Kidney J. 12(5), 702–720. <https://doi.org/10.1093/ckj/sfz011>
17. Lele, S. R., Keim, J. L., Solymos, P. (2019) ResourceSelection: Resource Selection (Probability) Functions for Use-Availability Data (R package version 0.3-5). Available at: https://CRAN.R-project.org/package=ResourceSelection
18. López-Ratón, M., Rodríguez-Álvarez, M. X., Suárez, C. C., Sampedro, F. G. (2014) OptimalCutpoints: An R package for selecting optimal cutpoints in diagnostic tests. J. Stat. Softw. 61(8), 1–36. <https://doi.org/10.18637/jss.v061.i08>
19. Mach, F., Baigent, C., Catapano, A. L., Koskinas, K. C., Casula, M., Badimon, L., Chapman, M. J., De Backer, G. G., Delgado, V., Ference, B. A., Graham, I. M., Halliday, A., Landmesser, U., Mihaylova, B., Pedersen, T. R., Riccardi, G., Richter, D. J., Sabatine, M. S., Taskinen, M. R., Tokgozoglu, L., Wiklund, O.; ESC Scientific Document Group (2020) 2019 ESC/EAS Guidelines for the management of dyslipidaemias: Lipid modification to reduce cardiovascular risk. Eur. Heart J. 41(1), 111–188. <https://doi.org/10.1093/eurheartj/ehz455>
20. Mancia, G., Fagard, R., Narkiewicz, K., Redon, J., Zanchetti, A., Böhm, M., Christiaens, T., Cifkova, R., De Backer, G., Dominiczak, A., Galderisi, M., Grobbee, D. E., Jaarsma, T., Kirchhof, P., Kjeldsen, S. E., Laurent, S., Manolis, A. J., Nilsson, P. M., Ruilope, L. M., Schmieder, R. E., Sirnes, P. A., Sleight, P., Viigimaa, M., Waeber, B., Zannad, F.; Task Force Members (2013) 2013 ESH/ESC guidelines for the management of arterial hypertension: The Task Force for the management of arterial hypertension of the European Society of Hypertension (ESH) and of the European Society of Cardiology (ESC). Eur. Heart J. 34(28), 2159–2219.
21. Matsushita, K., Ballew, S. H., Coresh, J. (2016) Cardiovascular risk prediction in people with CKD. Curr. Opin. Nephrol. Hypertens. 25(6), 518–523. <https://doi.org/10.1097/MNH.0000000000000265>
22. Moran, A. E., Forouzanfar, M. H., Roth, G. A., Mensah, G. A., Ezzati, M., Murray, C. J. L. (2014) Temporal trends in ischemic heart disease mortality in 21 world regions, 1980 to 2010: The Global Burden of Disease 2010 Study. Circulation 129(14), 1483–1492. <https://doi.org/10.1161/CIRCULATIONAHA.113.004042>
23. Mostovoy, Y. M., Sidorov, O. O. (2016) Laboratory Tests. Normal Values, Interpretation of Changes. Center DZK.
24. Orange Health Consultants (2018) Health Care in Ukraine. Commissioned by the Netherlands Enterprise Agency.
25. Orlandi, M., Barsotti, S., Lepri, G., Codullo, V., Battista, M. D., Guiducci, S., Rossa, A. D. (2018) One year in review 2018: Systemic sclerosis. Clin. Exp. Rheumatol. 113(4), 3–23 (Suppl. 36).
26. Osawa, K., Nakanishi, R., Budoff, M. (2016) Coronary artery calcification; report from the Multi-Ethnic Study of Atherosclerosis. Glob. Heart 11(3), 287–293. <https://doi.org/10.1016/j.gheart.2016.08.001>
27. Piepoli, M. F., Hoes, A. W., Agewall, S., Albus, C., Brotons, C., Catapano, A. L., Cooney, M. T., Corrà, U., Cosyns, B., Deaton, C., Graham, I., Hall, M. S., Hobbs, F. D. R., Løchen, M. L., Löllgen, H., Marques-Vidal, P., Perk, J., Prescott, E., Redon, J., Richter, D., Sattar, N., Smulders, Y., Tiberi, M., van der Worp, H. B., van Dis, I., Verschuren, W. M. M., Binno, S.; ESC Scientific Document Group (2016) 2016 European Guidelines on cardiovascular disease prevention in clinical practice. Eur. Heart J. 37(29), 2315–2381. <https://doi.org/10.1093/eurheartj/ehw106>
28. Pletcher, M. (2016) When Is Measuring a Coronary Artery Calcium Score Cost Effective? American College of Cardiology. Available at: https://www.acc.org/latest-in-cardiology/articles/2016/06/14/09/17/when-is-measuring-a-coronary-artery-calcium-score-cost-effective
29. R Core Team (2020) R: A Language and Environment for Statistical Computing (3.6.3) [R]. R Foundation for Statistical Computing. Available at: https://www.R-project.org/
30. Robin, X., Turck, N., Hainard, A., Tiberti, N., Lisacek, F., Sanchez, J.-C., Müller, M. (2011) pROC: An open-source package for R and S+ to analyze and compare ROC curves. BMC Bioinformatics 12(1), 77. <https://doi.org/10.1186/1471-2105-12-77>
31. Schrier, R. W. (2010) Aldosterone “escape” vs “breakthrough”. Nat. Rev. Nephrol. 6(2), 61. <https://doi.org/10.1038/nrneph.2009.228>
32. Sing, T., Sander, O., Beerenwinkel, N., Lengauer, T. (2005) ROCR: Visualizing classifier performance in R. Bioinformatics 21(20), 7881. <https://doi.org/10.1093/bioinformatics/bti623>
33. Thompson, S., James, M., Wiebe, N., Hemmelgarn, B., Manns, B., Klarenbach, S., Tonelli, M. (2015) Cause of death in patients with reduced kidney function. J. Am. Soc. Nephrol. 26(10), 2504–2511. <https://doi.org/10.1681/ASN.2014070714>
34. Timmis, A., Townsend, N., Gale, C., Grobbee, R., Maniadakis, N., Flather, M., Wilkins, E., Wright, L., Vos, R., Bax, J., Blum, M., Pinto, F., Vardas, P.; ESC Scientific Document Group (2018) European Society of Cardiology: Cardiovascular disease statistics 2017. Eur. Heart J. 39(7), 508–579. <https://doi.org/10.1093/eurheartj/ehx628>
35. Valdivielso, J. M., Rodríguez-Puyol, D., Pascual, J., Barrios, C., Bermúdez-López, M., Sánchez-Niño, M. D., Pérez-Fernández, M., Ortiz, A. (2019) Atherosclerosis in chronic kidney disease: More, less, or just different? Arterioscler. Thromb. Vasc. Biol. 39(10), 1938–1966. <https://doi.org/10.1161/ATVBAHA.119.312705>
36. Van Kempen, B. J. H., Spronk, S., Koller, M. T., Elias-Smale, S. E., Fleischmann, K. E., Ikram, M. A., Krestin, G. P., Hofman, A., Witteman, J. C. M., Hunink, M. G. M. (2011) Comparative effectiveness and cost-effectiveness of computed tomography screening for coronary artery calcium in asymptomatic individuals. J. Am. Coll. Cardiol. 58(16), 1690–1701. <https://doi.org/10.1016/j.jacc.2011.05.056>
37. Vedanthan, R., Choi, B. G., Baber, U., Narula, J., Fuster, V. (2014) Bioimaging and subclinical cardiovascular disease in low- and middle-income countries. J. Cardiovasc. Transl. Res. 7(8), 701–710. <https://doi.org/10.1007/s12265-014-9588-y>
38. Whelton, P. K., Carey, R. M., Aronow, W. S., Ovbiagele, B., Casey, D. E., Smith, S. C., Collins, K. J., Spencer, C. C., Himmelfarb, C. D., Stafford, R. S., Depalma, S. M., Taler, S. J., Gidding, S., Thomas, R. J., Jamerson, K. A., Williams, K. A., Jones, D. W., Williamson, J. D., Maclaughlin, E. J., Muntner, P., Ovbiagele, B., Smith, S. C., Spencer, C. C., Stafford, R. S., Taler, S. J., Thomas, R. J., Williams, K. A., Williamson, J. D., Wright, J. T. (2018) 2017 ACC/AHA/AAPA/ABC/ACPM/AGS/APhA/ASH/ASPC/NMA/PCNA Guideline for the prevention, detection, evaluation, and management of high blood pressure in adults: Executive summary: A report of the American College of Cardiology/American Heart Association Task Force on clinical practice guidelines. Hypertension 71(6), 1269–1324. <https://doi.org/10.1161/HYP.0000000000000066>
39. Williams, B., Mancia, G., Spiering, W., Agabiti Rosei, E., Azizi, M., Burnier, M., Clement, D., Coca, A., de Simone, G., Dominiczak, A., Kahan, T., Mahfoud, F., Redon, J., Ruilope, L., Zanchetti, A., Kerins, M., Kjeldsen, S. E., Kreutz, R., Laurent, S., Lip, G. Y. H., McManus, R., Narkiewicz, K., Ruschitzka, F., Schmieder, R. E., Shlyakhto, E., Tsioufis, C., Aboyans, V., Desormais, I.; ESC Scientific Document Group (2018) 2018 ESC/ESH Guidelines for the management of arterial hypertension. Eur. Heart J. 39(33), 3021–3104. <https://doi.org/10.1093/eurheartj/ehy339>
40. Zhao, Y., Malik, S., Wong, N. D. (2014) Evidence for coronary artery calcification screening in the early detection of coronary artery disease and implications of screening in developing countries. Glob. Heart 9(4), 399. <https://doi.org/10.1016/j.gheart.2014.10.005>
front cover

ISSN 1214-6994 (Print) ISSN 2336-2936 (Online)

Archive